Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 2/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.35 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.35 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.35 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ASPH | Q12797 | 1/20 | 0.34 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18645202 | 0.86 | ACKR3 (0.46) | CCNT1 | |
| SCHEMBL18285531 | 0.82 | JAK3 (0.47) | CUL4A | |
| SCHEMBL18285533 | 0.82 | JAK3 (0.47) | CUL4A | |
| SCHEMBL18285528 | 0.82 | JAK3 (0.47) | CUL4A | |
| SCHEMBL4737704 | 0.80 | PTGER4 (0.60) | PTGER4KDM4CUTS2R | |
| SCHEMBL28076725 | 0.78 | JAK3 (0.40) | CUL4A | |
| SCHEMBL28076726 | 0.78 | JAK3 (0.40) | CUL4A | |
| SCHEMBL3993362 | 0.77 | MAPK1 (0.43) | ALDH1A1 | |
| SCHEMBL3995252 | 0.77 | MAPK1 (0.43) | ALDH1A1 | |
| SCHEMBL3995260 | 0.77 | MAPK1 (0.43) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105753863-A | Oxo-dihydroimidazopyridine compound and application thereof | 东莞市真兴贝特医药技术有限公司 | 2016-07-13 | — | — | CN | disclosed |